Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathew J Garnett

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Drug Discovery Today|February 21, 2012
Exploiting genetic complexity in cancer to improve therapeutic strategiesMathew J Garnett, Ultan McDermott
Cancer Discovery|May 3, 2017
A Road Map for Precision Cancer Medicine Using Personalized ModelsGabriele Picco, Mathew J Garnett
Cancer Cell|October 19, 2004
Guilty as charged: B-RAF is a human oncogeneMathew J Garnett, Richard Marais
Current Opinion in Genetics & Development|March 11, 2014
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug responseMathew J Garnett, Ultan McDermott
Pharmacogenomics|October 21, 2015
What role could organoids play in the personalization of cancer treatment?Hayley E Francies, Mathew J Garnett
Nature Cancer|February 5, 2022
Genomics-guided pre-clinical development of cancer therapiesHayley E Francies, Ultan McDermott, Mathew J Garnett
Genome Biology|April 27, 2026
BEstimate: a computational tool for the design and interpretation of CRISPR base editing experimentsCansu Dinçer, Bo Fussing, Mathew J Garnett, et al.
Molecular Cell|December 21, 2005
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerizationMathew J Garnett, Sareena Rana, Hugh Paterson, et al.
Cancer Discovery|June 1, 2022
Can Drug Repurposing Accelerate Precision Oncology?Luuk J Schipper, Laurien J Zeverijn, Mathew J Garnett, et al.
Scientific Data|October 4, 2017
High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancerSteven P Williams, Andrew S Barthorpe, Howard Lightfoot, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Drug Discovery Today|February 21, 2012
Exploiting genetic complexity in cancer to improve therapeutic strategiesMathew J Garnett, Ultan McDermott
Cancer Discovery|May 3, 2017
A Road Map for Precision Cancer Medicine Using Personalized ModelsGabriele Picco, Mathew J Garnett
Cancer Cell|October 19, 2004
Guilty as charged: B-RAF is a human oncogeneMathew J Garnett, Richard Marais
Current Opinion in Genetics & Development|March 11, 2014
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug responseMathew J Garnett, Ultan McDermott
Pharmacogenomics|October 21, 2015
What role could organoids play in the personalization of cancer treatment?Hayley E Francies, Mathew J Garnett
Nature Cancer|February 5, 2022
Genomics-guided pre-clinical development of cancer therapiesHayley E Francies, Ultan McDermott, Mathew J Garnett
Genome Biology|April 27, 2026
BEstimate: a computational tool for the design and interpretation of CRISPR base editing experimentsCansu Dinçer, Bo Fussing, Mathew J Garnett, et al.
Molecular Cell|December 21, 2005
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerizationMathew J Garnett, Sareena Rana, Hugh Paterson, et al.
Cancer Discovery|June 1, 2022
Can Drug Repurposing Accelerate Precision Oncology?Luuk J Schipper, Laurien J Zeverijn, Mathew J Garnett, et al.
Scientific Data|October 4, 2017
High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancerSteven P Williams, Andrew S Barthorpe, Howard Lightfoot, et al.
Pageof 11